EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 20 (2), 161-169
- https://doi.org/10.1023/a:1022696012668
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.2001
- Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma2001
- E-cadherin and ?-, ?-, and ?-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusionsThe Journal of Pathology, 2000
- Tumor‐derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38FEBS Letters, 1998
- Generation of Monoclonal Antibodies to Integrin-associated ProteinsJournal of Biological Chemistry, 1997
- Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.1997
- Enhanced expression of a tumor‐cell‐derived collagenase‐stimulatory factor in urothelial carcinoma: Its usefulness as a tumor marker for bladder cancersInternational Journal of Cancer, 1993
- Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.1993
- Complete one-hour immunocytochemistry based on capillary action.1992
- Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factorArchives of Biochemistry and Biophysics, 1991